Bjorn Petri

Dr. Bjorn Petri


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2018 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
BPBjorn Petri
Bjorn Petri
MSMaria-Jesus Sanz
Maria-Jesus Sanz

30 January 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
JZJack Zhang
Jack Zhang
JCJohn Conly
John Conly
JMJoAnn McClure
JoAnn McClure
KWKaiyu Wu
Kaiyu Wu
BPBjorn Petri
Bjorn Petri
KZKunyan Zhang
Kunyan Zhang
USA300 is a predominant and highly virulent community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strain that is a leading cause of skin and soft tissue infections. We established a murine intradermal infection model capable of demonstrating dermatopathological differences between USA300 and other MRSA strains. In this model, USA300 induced dermonecrosis, uniformly presenting as extensive open lesions with a histologically documented profound inflammatory cell infiltrate extending below the subcutis. In contrast, USA400 and a colonizing control strain M92 caused only localized non-ulcerated skin infections associated with a mild focal inflammatory infiltrate. It was also determined that the dermonecrosis induced by USA300 was associated with significantly increased neutrophil recruitment, inhibition of an antibacterial response, and increased production of cytokines/chemokines associated with disease severity. These results suggest that induction of severe skin lesions by USA300 is related to over-activation of neutrophils, inhibition of host antibacterial responses, and selective alteration of host cytokine/chemokine profiles.